The Electronic Properties of Cordycepin in the Adenine Nucleoside Landscape: A Theoretical Approach

虫草素在腺嘌呤核苷体系中的电子性质:一种理论方法

阅读:1

Abstract

The anticancer activity of 3'-deoxyadenosine (Cordycepin, or dCor) is known to be linked to the inhibition of the MAPK/ERK signalling and Hedgehog pathways, as well as the termination of primer elongation by primase in DNA lagging-strand synthesis. In this study, the electronic properties of dCor, 7,8-dihydro-8-oxo-3'-deoxyadenosine ((OXO)dCor), and 8-hydroxy-3'deoxyadenosie ((HO)dCor), together with their spin densities, charge distributions, and global reactive descriptors, have been taken into consideration at the M06-2x/6-31++G** level of theory in the aqueous phase. It was found that dCor predominantly adopts a 3'-endo,anti conformation, while (OXO)dCor and (HO)dCor adopt a 2'-endo,syn conformation. Also, the keto form of oxidised dCor was found to be energetically preferred to its enolic form. The adiabatic ionisation potentials (AIPs) were noted as follows (in eV): 6.29 for dCor, 6.21 for (OXO)dCor, and 6.17 for (HO)dCor. The lowest adiabatic electron affinity among all the discussed adenine nucleosides analogues was assigned for (OXO)dCor at 1.12 eV. A thorough analysis of the spin density distribution of the adiabatic radical cation reveals that it has a higher accumulation at N6 > C5 > C8 > 3 of dCor, C5 > N6 > N7 > O8 of (OXO)dCor, and N6 > C5 > C8 > C2 of (HO)dCor. The results suggest that Cordycepin is more easily converted to (OXO)dCor and (HO)dCor than canonical adenine nucleosides. Much like typical drugs, after its administration and release, Cordycepin is exposed to various physiological factors and can be exposed to ionisation radiation during combined therapy. These factors can influence the therapeutic potential of Cordycepin. Therefore, further studies on its stability are of utmost importance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。